Deletion of Prepl Causes Growth Impairment and Hypotonia in Mice

DSpace/Manakin Repository

Deletion of Prepl Causes Growth Impairment and Hypotonia in Mice

Citable link to this page

 

 
Title: Deletion of Prepl Causes Growth Impairment and Hypotonia in Mice
Author: Lone, Anna Mari; Leidl, Mathias; McFedries, Amanda K.; Horner, James W.; Creemers, John; Saghatelian, Alan

Note: Order does not necessarily reflect citation order of authors.

Citation: Lone, Anna Mari, Mathias Leidl, Amanda K. McFedries, James W. Horner, John Creemers, and Alan Saghatelian. 2014. “Deletion of Prepl Causes Growth Impairment and Hypotonia in Mice.” PLoS ONE 9 (2): e89160. doi:10.1371/journal.pone.0089160. http://dx.doi.org/10.1371/journal.pone.0089160.
Full Text & Related Files:
Abstract: Genetic studies of rare diseases can identify genes of unknown function that strongly impact human physiology. Prolyl endopeptidase-like (PREPL) is an uncharacterized member of the prolyl peptidase family that was discovered because of its deletion in humans with hypotonia-cystinuria syndrome (HCS). HCS is characterized by a number of physiological changes including diminished growth and neonatal hypotonia or low muscle tone. HCS patients have deletions in other genes as well, making it difficult to tease apart the specific role of PREPL. Here, we develop a PREPL null (PREPL−/−) mouse model to address the physiological role of this enzyme. Deletion of exon 11 from the Prepl gene, which encodes key catalytic amino acids, leads to a loss of PREPL protein as well as lower Prepl mRNA levels. PREPL−/− mice have a pronounced growth phenotype, being significantly shorter and lighter than their wild type (PREPL+/+) counterparts. A righting assay revealed that PREPL−/− pups took significantly longer than PREPL+/+ pups to right themselves when placed on their backs. This deficit indicates that PREPL−/− mice suffer from neonatal hypotonia. According to these results, PREPL regulates growth and neonatal hypotonia in mice, which supports the idea that PREPL causes diminished growth and neonatal hypotonia in humans with HCS. These animals provide a valuable asset in deciphering the underlying biochemical, cellular and physiological pathways that link PREPL to HCS, and this may eventually lead to new insights in the treatment of this disease.
Published Version: doi:10.1371/journal.pone.0089160
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938459/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:12064428
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters